RadNet, Inc.
RDNT · Healthcare · $4.6B mkt cap · FY2025 filings · No moat ·
Doesn't clear the bar
The four filters
Median gross margin 12.6% over 4y, stable.
Median ROIC 4.4%, above the 9% hurdle in 0% of years.
Net debt/EBITDA 1.5x, interest coverage 1x.
Owner earnings trend unclear, share count growing (dilution).
Margin of safety
- Owner earnings (normalized)
- $3.0M
- Est. intrinsic value / share
- $0.46
- Recent price
- $62.19
- Discount to value
- 13513% above value
Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).
18 years of fundamentals
The business, in plain English
Across the filed record, revenue grew from $527.6M (FY2009) to $2.0B (FY2025) — about 8.8% a year compounded over 16 years.
It earned 2.9% on invested capital in FY2025, with a median of 3.6% across 15 filed years. The Returns on Capital filter above scores it 0/100.
The balance sheet carried $1.1B of total debt in FY2025. Balance-Sheet Safety scores it 34/100.
The share count rose 98.9% between FY2010 and FY2025 — existing owners have been diluted over the record. Capital Discipline scores it 24/100.
Put together: Balance-Sheet Safety is the strongest of the four filters (34/100) and Returns on Capital the weakest (0/100), which is how RDNT lands at 19/100 — a None moat.
This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.
Gaps in a line mean that item isn’t in RDNT’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.
Moat Score history
Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
None yet — RDNT has read No moat for every logged capture since Jul 17, 2026.
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Healthcare context
#414 of 440 scored Healthcare companies, ranked by Moat Score.
Nearest peers by Moat Score
- #412FEIM Frequency Electronics, Inc.19.0 out of 100, No moatNo moat
- #413SONX Sonendo, Inc.19.0 out of 100, No moatNo moat
- #415PLSH Panacea Life Sciences Holdings, Inc.18.7 out of 100, No moatNo moat
- #416CRON CRONOS GROUP INC.18.7 out of 100, No moatNo moat
Compare RDNT with its nearest peers →All Healthcare companies on the Index →
Common questions about RDNT
- Does RadNet, Inc. have an economic moat?
- Based on its FY2025 SEC filings, the Moat Index scores RadNet, Inc. (RDNT) 18.9 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 24, returns on capital 0, balance-sheet safety 34, capital discipline 24.
- Is RDNT stock trading below its intrinsic value?
- Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $0.46 per share versus a recent price of $62.19 — 13513% above value. This is an educational estimate computed from primary SEC filings, not investment advice.
- How has RDNT's Moat Score changed over time?
- The record logs 3 readings since Jul 17, 2026; the latest reads 18.9 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.